127 related articles for article (PubMed ID: 8295827)
1. Drug effects on cerebral blood flow in the baboon model--acetazolamide and nimodipine.
Oliver DW; Dormehl IC; Redelinghuys IF; Hugo N; Beverly G
Nuklearmedizin; 1993 Dec; 32(6):292-8. PubMed ID: 8295827
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow effects of sodium valproate in drug combinations in the baboon model.
Oliver DW; Dormehl IC
Arzneimittelforschung; 1998 Nov; 48(11):1058-63. PubMed ID: 9850424
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
[TBL] [Abstract][Full Text] [Related]
4. Non-human primate SPECT model for determining cerebral perfusion effects of cerebrovasoactive drugs acting via multiple modes of pharmacological action.
Oliver DW; Dormehl IC; Louw WK
J Neurol Sci; 2005 Mar; 229-230():255-9. PubMed ID: 15760648
[TBL] [Abstract][Full Text] [Related]
5. Cerebral blood flow effects of the nitric oxide donor, nitroglycerin and its drug combinations in the non-human primate model.
Oliver DW; Dormehl IC
Arzneimittelforschung; 1999 Sep; 49(9):732-9. PubMed ID: 10514899
[TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide.
Jordaan B; Oliver DW; Dormehl IC; Hugo N
Arzneimittelforschung; 1996 Sep; 46(9):844-7. PubMed ID: 8876930
[TBL] [Abstract][Full Text] [Related]
7. Dose response from pharmacological interventions for CBF changes in a baboon model using 99Tcm-HMPAO and SPECT.
Dormehl IC; Oliver DW; Hugo N
Nucl Med Commun; 1993 Jul; 14(7):573-7. PubMed ID: 8355917
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
Makino K; Masuda Y; Gotoh S
Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
[TBL] [Abstract][Full Text] [Related]
9. Cerebral blood flow effects of sumatriptan in drug combinations in the baboon model.
Dormehl IC; Oliver DW; Hugo N
Arzneimittelforschung; 1995 Sep; 45(9):952-6. PubMed ID: 7488311
[TBL] [Abstract][Full Text] [Related]
10. Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
Burt RW; Witt RM; Cikrit D; Carter J
Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809
[TBL] [Abstract][Full Text] [Related]
11. A comparative cerebral blood flow study in a baboon model with acetazolamide provocation: 99mTc-HMPAO vs 123I(IMP).
Dormehl IC; Oliver DW; Hugo N; Rossouw D
Nucl Med Biol; 1995 Apr; 22(3):373-8. PubMed ID: 7627153
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cerebral vasoreactivity by SPECT and transcranial Doppler sonography using the acetazolamide test.
Pávics L; Grünwald F; Barzó P; Ambrus E; Menzel C; Schomburg A; Borda L; Máté E; Bodosi M; Csernay L
Nuklearmedizin; 1994 Dec; 33(6):239-43. PubMed ID: 7854920
[TBL] [Abstract][Full Text] [Related]
13. The influence of acetazolamide on cerebral low-flow regions in migraine--an interictal 99mTc-HMPAO SPECT study.
Schlake HP; Böttger IG; Grotemeyer KH; Husstedt IW; Oberwittler C; Schober O
Cephalalgia; 1992 Oct; 12(5):284-8; discussion 267. PubMed ID: 1423558
[TBL] [Abstract][Full Text] [Related]
14. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.
Knop J; Thie A; Fuchs C; Siepmann G; Zeumer H
Stroke; 1992 Dec; 23(12):1733-42. PubMed ID: 1448823
[TBL] [Abstract][Full Text] [Related]
16. [Linealization correction for acetazolamide (Diamox) 99mTc-HMPAO SPECT image--a comparative study with PET].
Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1994 Mar; 31(3):277-82. PubMed ID: 8176867
[TBL] [Abstract][Full Text] [Related]
17. [The value of the acetazolamide stimulation test with 99mTc-HMPAO-SPECT in reversible cerebrovascular insufficiency].
Dingler WH; Deininger HK
Rofo; 1991 Nov; 155(5):465-71. PubMed ID: 1954368
[TBL] [Abstract][Full Text] [Related]
18. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
Matsuda H; Higashi S; Kinuya K; Tsuji S; Nozaki J; Sumiya H; Hisada K; Yamashita J
Clin Nucl Med; 1991 Aug; 16(8):572-9. PubMed ID: 1934810
[TBL] [Abstract][Full Text] [Related]
19. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography.
Kim E; Sohn CH; Na DG; Kim JE; Chang KH; Kim JH; Jeon SJ
J Comput Assist Tomogr; 2009; 33(4):546-51. PubMed ID: 19638847
[TBL] [Abstract][Full Text] [Related]
20. Influence of intravenously administered lidocaine on cerebral blood flow in a baboon model standardized under controlled general anaesthesia using single-photon emission tomography and technetium-99m hexamethylpropylene amine oxime.
Dormehl IC; Lipp MD; Hugo N; Daublaender M; Picard JA
Eur J Nucl Med; 1993 Nov; 20(11):1095-8. PubMed ID: 8287877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
